June 8, 1993 |
Disease Detection International Inc., a maker of pregnancy and AIDS testing kits, said Monday that it has sold $3 million worth of convertible preferred stock in a private placement--which should help get the company's common stock listed on the NASDAQ market for small corporations. The Irvine concern said it will ask owners of the common stock to approve a 1-for-10 reverse split at the annual meeting in July. That means the 10.
October 20, 1992 |
Disease Detection International Inc., a medical test kit manufacturer and distributor, said Monday that it has formed a subsidiary to distribute a new non-prescription pregnancy test. The new firm, FHC Corp., will market the one-step pregnancy test, Pro-Step hCG, to over-the-counter pharmacies, said chief executive H. Thad Morris. The product, which will be distributed under a new, as-yet-to-be-decided name, should be on the market by early next year, company officials announced.
February 7, 1992 |
A Michigan investor has filed suit against Disease Detection International Inc. and its president, accusing them of making false or misleading statements about the future prospects of the money-losing maker of medical diagnostic kits. Daniel J. Trierweiler, a Rockford, Mich.-based developer who also operates a Burger King franchise, filed the suit last December in U.S. District Court in Grand Rapids, Mich. The suit names 28 defendants, including former Interior Secretary James G.
January 26, 1993 |
The developer of a seven-minute AIDS test and its former parent company have traded temporary restraining orders over the ownership of technology. Editek Inc. in Burlington, N.C., and Disease Detection International Inc. in Irvine are arguing over a licensing agreement they made in 1985, when Editek formed Disease Detection. The subsidiary was spun off in 1988. Over the years, both companies have continued to develop biological tests.
August 8, 1991 |
Disease Detection International Inc. said Wednesday that the Food and Drug Administration has approved the sale of its quick, one-step pregnancy test to hospitals and doctors' offices, a move the company hopes will be a springboard for its entry into the lucrative over-the-counter market.